Where Will Eli Lilly Stock be In 2028?

Quick Read

• LLY grew gross 55% successful a azygous 4th with Mounjaro and Zepbound generating $13 cardinal combined, yet shares are level twelvemonth to date.

• Wall Street's $1,215 statement underestimates the 2028 setup, with Q1 EPS up 170% twelvemonth implicit twelvemonth and Foundayo's planetary oral GLP-1 motorboat not yet afloat ramped.

• A $1,500 people by 2028 is credible if Foundayo scales internationally, retatrutide clears Phase III, and Medicare Part D expands sum arsenic expected.

• Act now: the expert who called NVIDIA successful 2010 conscionable named his apical 10 AI stocks — and Eli Lilly didn't marque the cut. Grab the names FREE today.

Eli Lilly (NYSE:LLY) conscionable grew gross 55.5% successful a azygous 4th portion raising full-year guidance to $82 cardinal to $85 billion. Mounjaro and Zepbound combined for $12.8 cardinal successful Q1 alone. Yet shares are up conscionable 1.11% twelvemonth to date, sitting astatine $1,082.92. Can LLY scope $1,500 a stock by 2028?

Why Lilly Shares Have Stalled successful 2026

Fundamentals are accelerating portion the banal is flat. LLY is up 6.29% implicit the past week and 24.94% implicit the past month, recovering crushed mislaid during the early-2026 pullback from the December precocious adjacent $1,062.

The resistance is pricing. Realized prices fell 13% successful Q1 arsenic Mounjaro entered China's reimbursement database and Zepbound cash-pay tiers declined. Management guided to a low-to-mid-teens terms headwind for the afloat year. Investors are besides digesting $584M successful IPR&D charges tied to 4 acquisitions and $279M successful litigation charges. With a beta of 0.481, this is simply a prime compounder waiting for the marketplace to absorption connected volume.

Wall Street Sees 12% Upside. I Think That's Too Cautious.

The expert statement people sits astatine $1,215.10, with 6 beardown buys, 18 buys, 6 holds, and 1 sell. Our interior basal lawsuit lands astatine $1,243.22 with precocious assurance (0.9), and a bull-case 12-month work of $1,435.35.

Consensus is anchored to 2026 numbers and mostly ignores the 2028 setup. With 77% bullish sentiment, Q1 EPS maturation of 169.9% twelvemonth implicit year, and Foundayo's oral GLP-1 motorboat lone starting to ramp, analysts volition request to people up out-year models.

The Path to $1,500 Per Share

Reaching $1,500 from today's terms of $1,082.92 would necessitate a summation of 38.5%. With guardant EPS of $35.46, a terms of $1,500 implies a guardant P/E of 42x. Our basal lawsuit of $1,243.22 already implies 37x, meaning the bold people requires astir 5x further aggregate enlargement oregon equivalent EPS upside.

Act now: the expert who called NVIDIA successful 2010 conscionable named his apical 10 AI stocks — and Eli Lilly didn't marque the cut. Grab the names FREE today.